Table 3 Clinical, metabolic and cardiovascular autonomic parameters in patients with CGL subdivided into groups with and without left ventricular hypertrophy (n = 10)
Variables | LVH (n = 4) | No LVH (n = 6) | P |
|---|---|---|---|
Female, % (n) | 14 (6; 25) | 10 (7; 30) | 0.665 |
Age (years) | 75 (3) | 50 (3) | 0.571 |
pBMI (%) | 21.7 (18.7; 22.9) | 17.9 (16.2; 22.0) | 0.086 |
Systolic BP (mmHg) | 129 (110; 175) | 118 (90; 145) | 0.394 |
Diastolic BP (mmHg) | 84 (50; 109) | 76 (65; 90) | 0.392 |
Basal HR (bpm) | 83 (72; 96) | 95 (76; 109) | 0.136 |
30/15 coefficient | 1.04 (0.98; 1.59) | 1.20 (1.13; 1.57) | 0.199 |
Valsalvacoefficient | 1.33 (1.15; 1.82) | 1.64 (1.29; 2.34) | 0.201 |
E/I coefficient | 1.17 (1.09; 1.46) | 1.35 (1.27; 1.57) | 0.135 |
Reduction in SBP (mmHg) | 11 (6; 22) | 3.5 (0; 12) | 0.087 |
Component of very low frequency (Hz) | 350 (299; 694) | 652 (88; 4250) | 0.670 |
Component of low frequency (Hz) | 316 (139; 756) | 482 (158; 4294) | 0.670 |
Component of high frequency (Hz) | 235 (55; 603) | 905 (147; 1840) | 0.033 |
Total amplitude spectrum (Hz) | 898 (501; 2054) | 2389 (621; 9691) | 0.136 |
LF/HF ratio | 1.45 (1.18; 1.69) | 0.42 (0.12; 3.7) | 0.285 |